224 related articles for article (PubMed ID: 33603396)
1. Research Progress on Regulating LncRNAs of Hepatocellular Carcinoma Stem Cells.
Zhang X; Zhu Y
Onco Targets Ther; 2021; 14():917-927. PubMed ID: 33603396
[TBL] [Abstract][Full Text] [Related]
2. Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma.
Li N; Zhu Y
Therap Adv Gastroenterol; 2019; 12():1756284818821560. PubMed ID: 30719075
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA in liver cancer stem cells.
Cai Z; Xu K; Li Y; Lv Y; Bao J; Qiao L
Discov Med; 2017 Sep; 24(131):87-93. PubMed ID: 28972877
[TBL] [Abstract][Full Text] [Related]
4. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells.
Huo X; Han S; Wu G; Latchoumanin O; Zhou G; Hebbard L; George J; Qiao L
Mol Cancer; 2017 Oct; 16(1):165. PubMed ID: 29061150
[TBL] [Abstract][Full Text] [Related]
6. Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma.
Lv D; Chen L; Du L; Zhou L; Tang H
Front Cell Dev Biol; 2021; 9():691410. PubMed ID: 34368140
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
[TBL] [Abstract][Full Text] [Related]
8. IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells.
Li Y; Chen G; Han Z; Cheng H; Qiao L; Li Y
Onco Targets Ther; 2020; 13():9721-9730. PubMed ID: 33061451
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway.
Wei X; You X; Zhang J; Zhou C
Mol Ther Nucleic Acids; 2019 Jun; 16():721-732. PubMed ID: 31128423
[TBL] [Abstract][Full Text] [Related]
10. Alanine-Glyoxylate Aminotransferase Sustains Cancer Stemness Properties through the Upregulation of SOX2 and OCT4 in Hepatocellular Carcinoma Cells.
Ye P; Chi X; Yan X; Wu F; Liang Z; Yang WH
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625596
[TBL] [Abstract][Full Text] [Related]
11. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
[TBL] [Abstract][Full Text] [Related]
12. The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma.
Xiang Y; Yang T; Pang BY; Zhu Y; Liu YN
Stem Cells Int; 2016; 2016():7614971. PubMed ID: 27610139
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies.
Wang N; Wang S; Li MY; Hu BG; Liu LP; Yang SL; Yang S; Gong Z; Lai PBS; Chen GG
Ther Adv Med Oncol; 2018; 10():1758835918816287. PubMed ID: 30622654
[TBL] [Abstract][Full Text] [Related]
14. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
15.
Kwon M; Jung HJ
Cells; 2023 Dec; 13(1):. PubMed ID: 38201226
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies.
Liu YC; Yeh CT; Lin KH
Cells; 2020 May; 9(6):. PubMed ID: 32466488
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Liver Cancer Stem Cells: Non-coding RNAs, Oncogenes and Oncoproteins.
Li J; Zhu Y
Front Cell Dev Biol; 2020; 8():548335. PubMed ID: 33117795
[TBL] [Abstract][Full Text] [Related]
18. Actinomycin D inhibits the expression of the cystine/glutamate transporter xCT via attenuation of CD133 synthesis in CD133
Song Y; Park IS; Kim J; Seo HR
Chem Biol Interact; 2019 Aug; 309():108713. PubMed ID: 31226288
[TBL] [Abstract][Full Text] [Related]
19. Regulators of liver cancer stem cells.
Liu K; Ou JJ
World J Stem Cells; 2021 Aug; 13(8):1127-1133. PubMed ID: 34567430
[TBL] [Abstract][Full Text] [Related]
20. FEN1 upregulation mediated by SUMO2 via antagonizing proteasomal degradation promotes hepatocellular carcinoma stemness.
Peng Z; Wang S; Wen D; Mei Z; Zhang H; Liao S; Lv L; Li C
Transl Oncol; 2024 Jun; 44():101916. PubMed ID: 38513457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
